|Home||» Products||» Muscle Relaxant & Antispasmodic Drugs||» Calcitonin|
- Minimum Order Quantity
CALCINASE is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years post-menopause. Fracture reduction efficacy has not been demonstrated. CALCINASE should be Treatment of Postmenopausal Osteoporosis
reserved for patients who refuse or cannot tolerate oestrogens or in whom oestrogens are contraindicated.
Due to the possible association between malignancy and salmon calcitonin use, the need for continued therapy should be re-evaluated on a periodic basis. Salmon calcitonin nasal solutionhas not been shown to increase spinal bone mineral density in early postmenopausal women.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia